Metabolite regulation of adipocyte differentiation in obesity
肥胖症脂肪细胞分化的代谢调节
基本信息
- 批准号:10387771
- 负责人:
- 金额:$ 4.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-07 至 2025-02-06
- 项目状态:未结题
- 来源:
- 关键词:AcetatesAcetyl Coenzyme AAdipocytesAdipose tissueAdultAdvanced DevelopmentAffectAspartateAspartoacylaseBiological AssayBrainCRISPR/Cas technologyCanavan DiseaseCardiovascular DiseasesCellsChronicCitric Acid CycleCompetenceCoupledCritical ThinkingDataDepositionDifferentiated GeneEnergy MetabolismEnvironmentEnzymesEpidemiologyExperimental DesignsFatty acid glycerol estersFlow CytometryGene ExpressionGenerationsGenesGoalsGrowthHigh Fat DietHormone secretionHumanHyperglycemiaHypertrophyIn VitroInflammationInstitutionInsulin ResistanceKnock-outKnockout MiceLabelLearningLinkLipidsLiverMass Spectrum AnalysisMedicalMentorsMetabolicMetabolismMethodsMolecularMorphologyMusMyelinN-acetylaspartateNon-Insulin-Dependent Diabetes MellitusNucleotide BiosynthesisNutrientObesityOligodendrogliaOutcomePathway interactionsPeripheralPhenotypePhysiologic pulsePlayPrincipal InvestigatorRegulationResearchResearch ProposalsRoleScientistSourceTestingTissuesTrainingTriad Acrylic ResinVolatile Fatty Acidsadipocyte differentiationbasecarbohydrate metabolismcareer developmentcombatcomorbiditydefined contributionenergy balanceextracellularhistone modificationin vivoinsightinsulin sensitivitylipid biosynthesislipid metabolismloss of function mutationmetabolic phenotypemetabolomicsmortality riskmouse modelmyelin degenerationobese personprecursor cellpreservationresearch and developmentskill acquisitionskillstherapeutic developmenttooltranscriptome sequencingvalidation studies
项目摘要
ABSTRACT
The triad of obesity, insulin resistance, and type 2 diabetes mellitus (T2DM) affects roughly 33% of U.S. adults
and raises the risk of death from cardiovascular disease. The epidemiological association of obesity with T2DM
is unequivocal, but mechanistic links remain unclear. However, it is clear T2DM is distinctly associated with
defective fat cell (adipocyte) function, particularly energy storage as lipids and secretion of hormones for
systemic insulin sensitivity. We discovered the expression of the enzyme aspartoacylase (ASPA) in white
adipose tissue (WAT) correlates with insulin sensitivity in obese subjects. ASPA governs intracellular acetate
generation and myelin formation in the brain, but its effect in other tissues remains unknown. This
application's overall scientific objective is to unravel how ASPA and acetate contribute to lipid substrates in WAT
using well-established in vitro tools and mouse models of obesity. The central hypothesis is that ASPA-derived
acetate promotes adipocyte differentiation and systemic energy balance. I will test this hypothesis by pursuing
three specific aims: 1) Demonstrate how altered ASPA expression affects lipogenesis in white adipocytes;
2) Define the impact of extracellular acetate on adipogenic competency of precursor cells; 3) Establish the
metabolic effects of ASPA disruption in vivo. Mature adipocytes express high ASPA levels and byproducts of
ASPA activity flow into lipogenesis, nucleotide biosynthesis, and histone modifications. Therefore, ASPA function
likely integrates multiple pathways necessary for adipocytes to overcome nutrient demands in obesity. Lastly,
the mentor and training environment will build research and career development skills to realize my ultimate goal
of becoming an independent scientist.
抽象的
肥胖、胰岛素抵抗和 2 型糖尿病 (T2DM) 三联症影响着大约 33% 的美国成年人
并增加因心血管疾病死亡的风险。肥胖与 T2DM 的流行病学关联
是明确的,但机制联系仍不清楚。然而,很明显 T2DM 与
脂肪细胞(脂肪细胞)功能有缺陷,特别是脂质能量储存和激素分泌
全身胰岛素敏感性。我们发现白色中表达天冬氨酸酰化酶(ASPA)
肥胖受试者的脂肪组织(WAT)与胰岛素敏感性相关。 ASPA 控制细胞内醋酸盐
大脑中髓磷脂的生成和形成,但其对其他组织的影响仍不清楚。这
该应用程序的总体科学目标是揭示 ASPA 和乙酸盐如何影响 WAT 中的脂质底物
使用完善的体外工具和肥胖小鼠模型。中心假设是 ASPA 衍生的
醋酸盐促进脂肪细胞分化和全身能量平衡。我将通过追求来检验这个假设
三个具体目标:1) 展示 ASPA 表达的改变如何影响白色脂肪细胞的脂肪生成;
2) 明确细胞外乙酸盐对前体细胞成脂能力的影响; 3)建立
ASPA 破坏体内代谢的影响。成熟脂肪细胞表达高 ASPA 水平和副产物
ASPA 活性涉及脂肪生成、核苷酸生物合成和组蛋白修饰。因此,ASPA功能
可能整合了脂肪细胞克服肥胖营养需求所需的多种途径。最后,
导师和培训环境将培养研究和职业发展技能,以实现我的最终目标
成为一名独立科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JESSICA Beserra FELIX其他文献
JESSICA Beserra FELIX的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JESSICA Beserra FELIX', 18)}}的其他基金
Metabolite regulation of adipocyte differentiation in obesity
肥胖症脂肪细胞分化的代谢调节
- 批准号:
10569510 - 财政年份:2022
- 资助金额:
$ 4.68万 - 项目类别:
相似国自然基金
乙酰辅酶A合成酶2(ACSS2)调控内侧前额叶皮层神经元的活性在抑郁发病中的作用及机制研究
- 批准号:82301698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
乙酰磷酸通过调节乙酰辅酶A的合成影响大肠杆菌甲氧苄啶耐药性的分子机制研究
- 批准号:32370193
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
过氧化物酶体β-氧化通过乙酰辅酶A调控过氧化物酶体稳态的分子机制研究
- 批准号:32370738
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
乙酰辅酶A合成酶点突变在青蒿素类药物抗性中的作用及机制研究
- 批准号:32370543
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Metabolite regulation of adipocyte differentiation in obesity
肥胖症脂肪细胞分化的代谢调节
- 批准号:
10569510 - 财政年份:2022
- 资助金额:
$ 4.68万 - 项目类别:
Role of acetyl-CoA metabolism in the response to dietary and thermal stress
乙酰辅酶A代谢在饮食和热应激反应中的作用
- 批准号:
10909411 - 财政年份:2018
- 资助金额:
$ 4.68万 - 项目类别:
Mechanistic Target of Rapamycin Pathways in Metabolism and Energy Expenditure
雷帕霉素代谢和能量消耗途径的机制目标
- 批准号:
10615070 - 财政年份:2013
- 资助金额:
$ 4.68万 - 项目类别:
Mechanistic Target of Rapamycin Pathways in Metabolism and Energy Expenditure
雷帕霉素代谢和能量消耗途径的机制目标
- 批准号:
9904610 - 财政年份:2013
- 资助金额:
$ 4.68万 - 项目类别:
Mechanistic Target of Rapamycin Pathways in Metabolism and Energy Expenditure
雷帕霉素代谢和能量消耗途径的机制目标
- 批准号:
10398039 - 财政年份:2013
- 资助金额:
$ 4.68万 - 项目类别: